株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医薬品原薬 (API) の世界市場 (製造工程別、APIの種類別、医薬品の種類別、治療領域別):産業分析、市場規模・シェア・成長・動向・予測

Active Pharmaceutical Ingredients (API) Market (Manufacturing Process; API Type; Drug Type; Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023

発行 Transparency Market Research 商品コード 328538
出版日 ページ情報 英文 115 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.95円で換算しております。
Back to Top
医薬品原薬 (API) の世界市場 (製造工程別、APIの種類別、医薬品の種類別、治療領域別):産業分析、市場規模・シェア・成長・動向・予測 Active Pharmaceutical Ingredients (API) Market (Manufacturing Process; API Type; Drug Type; Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023
出版日: 2018年04月13日 ページ情報: 英文 115 Pages
概要

当レポートでは、世界の医薬品原薬 (API) 市場について調査し、市場収益の実績・予測を提供しており、市場の促進因子・阻害因子の分析、製造手法・APIの種類・医薬品の種類・治療領域および地域別の分析と予測、競合情勢、主要企業のプロファイルなどをまとめ、お届けいたします。

第1章 序論

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • イベントの影響度の分析
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • 市場求心力の分析:地域別
  • 競争環境:主要企業の市場規模

第4章 世界のAPI (医薬品原体) 市場:製造工程別

  • イントロダクション
  • 自家用製造 (社内生産):市場収益額 (金額ベース、通算11年間分)
  • 受託製造 (外注生産):市場収益額 (金額ベース、通算11年間分)

第5章 世界のAPI市場:APIの種類別

  • イントロダクション
  • 合成化学API:市場収益額 (金額ベース、通算11年間分)
  • 生物製剤API:市場収益額 (金額ベース、通算11年間分)

第6章 世界のAPI市場:医薬品の種類別

  • イントロダクション
  • ブランド処方薬向けAPI:市場収益額 (金額ベース、通算11年間分)
  • ジェネリック処方薬向けAPI:市場収益額 (金額ベース、通算11年間分)
  • 市販薬 (OTC) 向けAPI:市場収益額 (金額ベース、通算11年間分)

第7章 世界のAPI市場:治療領域別

  • イントロダクション
  • 心血管疾患治療薬用:市場収益額 (金額ベース、通算11年間分)
  • 代謝障害治療薬用:市場収益額 (金額ベース、通算11年間分)
  • 神経障害治療薬用:市場収益額 (金額ベース、通算11年間分)
  • 抗がん剤用:市場収益額 (金額ベース、通算11年間分)
  • 筋骨格障害治療薬用:市場収益額 (金額ベース、通算11年間分)
  • NSAID (非ステロイド系抗炎症薬) 治療薬用:市場収益額 (金額ベース、通算11年間分)
  • 他の治療薬用:市場収益額 (金額ベース、通算11年間分)

第8章 世界のAPI市場:地域別

  • イントロダクション
  • 北米のAPI市場:国別 (金額ベース、通算11年間分)
    • 米国、カナダ
  • アジア太平洋地域のAPI市場の収益額:国別 (金額ベース、通算11年間分)
    • 中国、日本、インドなど
  • 欧州のAPI市場:国別 (金額ベース、通算11年間分)
    • ドイツ、英国など
  • 他の国々 (RoW)

第9章 提言

  • 標的地域での企業買収を通じた生産能力拡張
  • 特定のAPI分子の領域におけるコスト主導権の獲得

第10章 企業プロファイル

  • Allergan plc
  • BASF SE
  • Boehringer Ingelheim GmbH
  • Cambrex Corporation
  • Dr. Reddy's Laboratories
  • Lonza Group
  • Mylan N.V.
  • Pfizer, Inc.
  • Sandoz (Novartis AG)
  • Teva Pharmaceutical Industries Ltd.
  • WuXi AppTec
目次

Title:
Active Pharmaceutical Ingredients (API) Market
(Manufacturing Process - Captive and Contract; API Type - Synthetic Chemical and Biological; Drug Type - Branded, Generic, and OTC; Therapeutic Area - Cardiovascular, Metabolic, Neurological, Oncology, Musculoskeletal, and NSAIDs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023.

Global Active Pharmaceutical ingredients Market: Overview

Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. APIs of good quality are essential for the manufacture of effective and safe medicines. However, not all pharmaceutical companies possess in-house API manufacturing capabilities. Furthermore, a single company cannot produce all the APIs required for their formulation offerings.

The report provides detailed qualitative analysis of the market dynamics that affect the growth of the global market. Factors responsible for driving and restraining the growth of the global API market and future opportunities has been provided in the market overview section. This section of the report also provides comprehensive market comparative analysis and market attractiveness analysis for the global market by geography for the base year, Porter's Five Forces analysis, and market share analysis by key players (%) for the base year, operating in the active pharmaceutical ingredients market. The report also encompasses detailed event impact analysis and value chain analysis for the global market.

Global Active Pharmaceutical ingredients Market: Segmentations

The global market has been broadly segmented on the basis of manufacturing process, type of API, types of drugs, therapeutic areas and geography. This report analyzes the current scenario as well as future market potential for market globally. This report comprises an elaborate executive summary, demonstrating a snapshot on market dynamics of various segments and sub-segments in a precise manner. Moreover, executive summary also comprises a waterfall chart, which reflects the market size of various segments in descending order.

The global API market is categorized in to captive manufacturing and contract manufacturing. Types of active pharmaceutical ingredients described in the global market include synthetic chemical API and biological API. Branded prescription drugs, generic prescription drugs, and over-the-counter drugs are various types of drugs covered in the global market. The global market encompasses various therapeutic areas such as cardiovascular disorders, oncology, metabolic disorders, neurological disorders, musculoskeletal disorders, NSAIDs and other therapeutic uses (such as infectious diseases). The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers.

Global Active Pharmaceutical ingredients Market: Regional Analysis

Geographies discussed and analyzed in the global market include North America, Europe, Asia Pacific, and Rest of the World. In addition the report also comprises the precise and detailed country wise analysis for the global active pharmaceutical ingredients market such as North America (U.S. and Canada), Asia Pacific (China, Japan, India and Rest of Asia Pacific), and Europe (Germany, U.K. and Rest of Europe). The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2013 to 2023. The report on the market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2017 to 2023, considering 2016 as the base year.

Global Active Pharmaceutical ingredients Market: Competitive Landscape

A list of recommendations have been provided for new entrants to help establish a strong presence and for existing market players to take strategic decisions and to increase their market shares in the global active pharmaceutical ingredient market. The report concludes with the profiles of major players in the market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Allergan plc, BASF SE, Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy's Laboratories Ltd., Lonza Group, Mylan, Inc., Sandoz (Novartis AG), Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and WuXi Apptec.

Key Segments of the Global Active Pharmaceutical Ingredients Market:

By Manufacturing Process

  • Captive Manufacturing
  • Contract Manufacturing

By API Type

  • Synthetic Chemical API
  • Biological API

By Drug Type

  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Prescription Drugs

By Therapeutic Area

  • Cardiovascular Disorders
  • Metabolic Disorders
  • Neurological Disorders
  • Oncology
  • Musculoskeletal Disorders
  • NSAIDs
  • Other Therapeutics Uses

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1: Preface

Chapter 2: Executive Summary

  • 2.1. Introduction
  • 2.2. Global Market: Market Snapshot
  • 2.3. Comparative Analysis: Global Active Pharmaceutical Ingredients Market, by Geography(2015 & 2023)
  • 2.4. Waterfall Diagram: Global API Market Revenue, by Therapeutic Area, 2015(US$ Mn)

Chapter 3: Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
      • 3.2.1.1. Increase in healthcare expenditure to drive market growth
      • 3.2.1.2. Rapidly aging of global population expected to aid growth of the API market
      • 3.2.1.3. Increase in Abbreviated New Drug Applications(ANDA) in the recent past to boost the demand for APIs
    • 3.2.2. Restraint
      • 3.2.2.1. Adverse regulatory policies to be an important restraining factor
    • 3.2.3. Opportunity
      • 3.2.3.1. Patent Expiry of Major Biological Drugs in the U.S. and EU
      • 3.2.3.2. Growth of the healthcare market in Asia-Pacific and rest of the world(RoW) segments
  • 3.3. Event Impact Analysis
  • 3.4. Value Chain Analysis
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness Analysis: Global Market, by Geography, 2015
  • 3.7. Competitive Landscape: Global Market, by Key Players, 2015(USD Million)

Chapter 4: By Manufacturing Process

  • 4.1. Introduction
  • 4.2. Captive Manufacturing Market Revenue, 2013-2023(US$ Mn)
  • 4.3. Contract Manufacturing Market Revenue, 2013-2023(US$ Mn)

Chapter 5: By API Type

  • 5.1. Introduction
  • 5.2. Synthetic Chemical Market Revenue, 2013-2023(US$ Mn)
  • 5.3. API Biological API Market Revenue, 2013-2023(US$ Mn)

Chapter 6: By Drug Type

  • 6.1. Introduction
  • 6.2. API Market Revenue for Branded Prescription Drugs, 2013-2023(US$ Mn)
  • 6.3. API Market Revenue for Generic Prescription Drugs, 2013-2023(US$ Mn)
  • 6.4. API Market Revenue for OTC Prescription Drugs, 2013-2023(US$ Mn)

Chapter 7: By Therapeutic Area

  • 7.1. Introduction
  • 7.2. API Market Revenue for Cardiovascular Disorders Drug, 2013-2023(US$ Mn)
  • 7.3. API Market for Drugs for Metabolic Disorders, 2013-2023(US$ Mn)
  • 7.4. API Market for Drugs for Neurological Disorders, 2013-2023(US$ Mn)
  • 7.5. API Market for Drugs for Oncology, 2013-2023(US$ Mn)
  • 7.6. API Market for Drugs for Musculoskeletal Disorders, 2013-2023(US$ Mn)
  • 7.7. API Market for NSAIDs, 2013-2023(US$ Mn)
  • 7.8. API Market for Drugs for Other Therapeutics Uses, 2013-2023(US$ Mn)

Chapter 8: By Region

  • 8.1. Introduction
  • 8.2. North America API Market Revenue, by Country, 2013-2023(US$ Mn)
    • 8.2.1. U.S. API Market Revenue,, 2013-2023,(US$ Mn)
    • 8.2.2. Canada API Market Revenue, 2013-2023,(US$ Mn)
  • 8.3. Asia-Pacific Market Revenue, by Country, 2013-2023(US$ Mn)
    • 8.3.1. China API Market Revenue,, 2013-2023,(US$ Mn)
    • 8.3.2. Japan API Market Revenue,, 2013-2023,(US$ Mn)
    • 8.3.3. India API Market Revenue,, 2013-2023,(US$ Mn)
    • 8.3.4. Rest of Asia-Pacific API Market Revenue,, 2013-2023,(US$ Mn)
  • 8.4. Europe
    • 8.4.1. Germany API Market Revenue,, 2013-2023,(US$ Mn)
    • 8.4.2. U.K. API Market Revenue,, 2013-2023,(US$ Mn)
    • 8.4.3. Rest of Europe API Market Revenue,, 2013-2023,(US$ Mn)
  • 8.5. Rest of the World

Chapter 9: Recommendations

  • 9.1. Enhance manufacturing capacity through acquisitions in targeted geographies
  • 9.2. Achieve cost leadership in specific API molecules

Chapter 10: Company Profiles

  • 10.1. Allergan plc
  • 10.2. BASF SE
  • 10.3. Boehringer Ingelheim GmbH
  • 10.4. Cambrex Corporation
  • 10.5. Dr. Reddy's Laboratories
  • 10.6. Lonza Group
  • 10.7. Mylan N.V.
  • 10.8. Pfizer, Inc.
  • 10.9. Sandoz(Novartis AG)
  • 10.10. Teva Pharmaceutical Industries Ltd.
  • 10.11. WuXi AppTec
Back to Top